Private Equity

Following a pivotal 2024 merger, California BanCorp appoints veteran banker and Chairman David Rainer as CEO, succeeding the retiring Steven Shelton.

NRG Energy names insider Robert J. Gaudette as its next CEO, signaling strategic continuity as the energy giant navigates a market in transformation.

A major new partnership aims to consolidate the industrial services sector, fueled by private equity and a national infrastructure spending boom.

As Sotera Health prepares for the J.P. Morgan conference, strong financials clash with legal challenges, putting its mission-critical role under scrutiny.

A landmark public-private deal secures Groupe Somavrac's future, safeguarding 500+ jobs and a critical link in Canada's St. Lawrence Seaway supply chain.

Lotus Infrastructure acquires a major Long Island power plant, a move that highlights the complex balance between grid reliability and clean energy mandates.

Tidewater Midstream solidifies its position in Alberta with new five-year agreements, promising stable revenue and high utilization at its key Brazeau River facility.

A new blood test in Western Canada promises to detect 59 cancers early. But with a high price tag and pending approval, it raises critical questions.

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

As millions of solar panels near retirement, a Nevada facility gets the final go-ahead to turn a looming waste crisis into a source of valuable materials.

A new survey shows strong optimism among U.S. firms, with leaders planning to hire, invest, and expand despite inflation and geopolitical headwinds.

A new alliance pairs Relation's 'Lab-in-the-Loop' AI with Deerfield's investment might, aiming to fast-track novel drugs for intractable diseases.

The renewable firm secures vital grid access for 2.9 GW in the UK and key approvals in Germany, setting the stage for major project divestments.

The Japanese government's 'SUI COLLECTION' is showcasing hidden artisanal treasures to the world, blending tradition with modern luxury in a bold cultural push.

A first-in-class antibody shows a strong safety profile, de-risking development and offering a new, targeted approach for severe autoimmune diseases.

A strategic bet on ethnic grocery-anchored retail pays off as Arc Capital Partners exits a revitalized Torrance center in a $108.5 million blockbuster deal.

A routine prenatal screen can now detect a virus that causes birth defects, offering a path to prevention and sparking calls to change medical guidelines.

With its first drug approved and a deep pipeline, all eyes are on Nuvation Bio's CEO David Hung at the upcoming J.P. Morgan Healthcare Conference.

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

With its acquisition of high-voltage expert Substations, Inc., Allied Services Group is strategically positioned to capitalize on Texas's massive energy boom.